Citigroup’s KORU Medical Systems KRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.9K Buy
2,291
+1,220
+114% +$6.05K ﹤0.01% 5042
2025
Q4
$6.22K Sell
1,071
-793
-43% -$3.8K ﹤0.01% 5185
2025
Q3
$7.14K Sell
1,864
-13,235
-88% -$50.6K ﹤0.01% 5116
2025
Q2
$54.1K Buy
15,099
+13,246
+715% +$37.6K ﹤0.01% 4714
2025
Q1
$4.71K Sell
1,853
-15,881
-90% -$59K ﹤0.01% 5282
2024
Q4
$68.3K Buy
17,734
+17,715
+93,237% +$57.5K ﹤0.01% 4991
2024
Q3
$52 Sell
19
-1,618
-99% -$3.99K ﹤0.01% 5561
2024
Q2
$4.34K Sell
1,637
-4,052
-71% -$9.27K ﹤0.01% 5273
2024
Q1
$13.4K Buy
5,689
+753
+15% +$1.61K ﹤0.01% 5131
2023
Q4
$12.1K Buy
4,936
+4,892
+11,118% +$11.7K ﹤0.01% 5143
2023
Q3
$119 Sell
44
-10,365
-100% -$28.4K ﹤0.01% 5384
2023
Q2
$35.9K Buy
+10,409
New +$40.9K ﹤0.01% 4796
2021
Q2
Sell
-1,784
Closed -$6K 6271
2021
Q1
$6K Sell
1,784
-3,162
-64% -$13.7K ﹤0.01% 5853
2020
Q4
$30K Buy
4,946
+3,382
+216% +$18.9K ﹤0.01% 6395
2020
Q3
$11K Sell
1,564
-6,266
-80% -$55.6K ﹤0.01% 6561
2020
Q2
$70K Buy
7,830
+2,971
+61% +$30K ﹤0.01% 5821
2020
Q1
$36K Buy
4,859
+3,592
+284% +$24.2K ﹤0.01% 6270
2019
Q4
$8K Buy
+1,267
New +$6.18K ﹤0.01% 7267

Other funds holding KRMD

Citigroup's KRMD Position: Q1 2026 in Review

Citigroup increased its KORU Medical Systems (KRMD) stake by 114% in Q1 2026, buying an estimated $6.05K and bringing the position to 2,291 shares worth $9.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5042.

Citigroup first reported a position in KRMD in Q4 2019 and has held it in 18 quarters since. The position peaked at $70K in Q2 2020. 91 funds tracked by Wall St. Rank hold KRMD as of Q1 2026.

  • Citigroup held 2,291 shares of KORU Medical Systems worth $9.9K as of Q1 2026.
  • Citigroup bought 1,220 KORU Medical Systems shares in Q1 2026, an estimated $6.05K.
  • KORU Medical Systems made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5042 holding.
  • Citigroup first reported a position in KORU Medical Systems in Q4 2019 and has held it in 18 quarters since.
  • Citigroup's KORU Medical Systems position peaked at $70K in Q2 2020.
  • 91 funds tracked by Wall St. Rank held KORU Medical Systems as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.